1. Home
  2. TKNO vs OVID Comparison

TKNO vs OVID Comparison

Compare TKNO & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

N/A

Current Price

$7.01

Market Cap

482.7M

Sector

Health Care

ML Signal

N/A

OVID

Ovid Therapeutics Inc.

N/A

Current Price

$2.25

Market Cap

421.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TKNO
OVID
Founded
1996
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
482.7M
421.8M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
TKNO
OVID
Price
$7.01
$2.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
13
Target Price
★ $9.67
$6.00
AVG Volume (30 Days)
564.9K
★ 1.6M
Earning Date
11-04-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 43.86
3.90
EPS
★ N/A
N/A
Revenue
★ $40,520,000.00
$7,252,000.00
Revenue This Year
$13.54
N/A
Revenue Next Year
$14.51
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
7.35
★ 1181.27
52 Week Low
$1.91
$1.18
52 Week High
$9.48
$3.11

Technical Indicators

Market Signals
Indicator
TKNO
OVID
Relative Strength Index (RSI) 46.18 44.02
Support Level $6.33 $2.09
Resistance Level $7.66 $2.87
Average True Range (ATR) 0.59 0.17
MACD -0.19 0.00
Stochastic Oscillator 53.90 27.68

Price Performance

Historical Comparison
TKNO
OVID

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: